Defendant

Canda HEC 1 LLC

1 case as defendant.

Cases
1
Active
1
0 closed
Filed
2020
Top venue
D. Delaware
1 case

Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al.

active
Docket:
1:20-cv-00133
Filed:
2020-01-28

Hatch-Waxman/ANDA patent infringement action by Novartis against HEC and related entities concerning generic fingolimod 0.5 mg capsules. Consolidated with 1:21-cv-01530 and 1:23-cv-00026; claim construction was decided on April 6, 2023 and merits briefing was ongoing.